RPR and the Serologic Diagnosis of SyphilisCLEMENT, Meredith E; HICKS, Charles B.JAMA, the journal of the American Medical Association. 2014, Vol 312, Num 18, pp 1922-1923, issn 0098-7484, 2 p.Article

Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infectionKAPLAN, Susan S; HICKS, Charles B.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 2, pp 273-276, issn 0305-7453, 4 p.Article

Primary human immunodeficiency virusTAIWO, Babafemi O; HICKS, Charles B.Southern medical journal (Birmingham). 2002, Vol 95, Num 11, pp 1312-1317, issn 0038-4348, 6 p.Article

Treatment of Syphilis: A Systematic ReviewCLEMENT, Meredith E; LANCE OKEKE, N; HICKS, Charles B et al.JAMA, the journal of the American Medical Association. 2014, Vol 312, Num 18, pp 1905-1917, issn 0098-7484, 13 p.Article

Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes : Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute InfectionALAM, S. Munir; SCEARCE, Richard M; XIA, Shi-Mao et al.Journal of virology. 2008, Vol 82, Num 1, pp 115-125, issn 0022-538X, 11 p.Article

Infrequent diagnosis of primary human immunodeficiency virus infection: Missed opportunities in acute care settingsWEINTROB, Amy C; GINER, Julieta; MENEZES, Prema et al.Archives of internal medicine (1960). 2003, Vol 163, Num 17, pp 2097-2100, issn 0003-9926, 4 p.Article

Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infectionGAY, Cynthia L; MAYO, Ashley J; MARGOLIS, David M et al.AIDS (London). 2011, Vol 25, Num 7, pp 941-949, issn 0269-9370, 9 p.Article

Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing populationPILCHER, Christopher D; MCPHERSON, J. Todd; LEONE, Peter A et al.JAMA, the journal of the American Medical Association. 2002, Vol 288, Num 2, pp 216-221, issn 0098-7484Article

HIV in body fluids during primary HIV infection : implications for pathogenesis, treatment and public healthPILCHER, Christopher D; SHUGARS, Diane C; ERON, Joseph J et al.AIDS (London). 2001, Vol 15, Num 7, pp 837-845, issn 0269-9370Article

Comparison of Once-Daily Fosamprenavir Boosted with Either 100 or 200 mg of Ritonavir, in Combination with Abacavir/Lamivudine : 96-Week Results from COL100758HICKS, Charles B; DEJESUS, Edwin; SLOAN, Louis M et al.AIDS research and human retroviruses. 2009, Vol 25, Num 4, pp 395-403, issn 0889-2229, 9 p.Article

In Vivo gp41 Antibodies Targeting the 2F5 Monoclonal Antibody Epitope Mediate Human Immunodeficiency Virus Type 1 Neutralization BreadthXIAOYING SHEN; PARKS, Robert J; GREENBERG, Michael L et al.Journal of virology. 2009, Vol 83, Num 8, pp 3617-3625, issn 0022-538X, 9 p.Article

Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysisBOHJANEN, Paul R; JOHNSON, Melissa D; SZCZECH, Lynda A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 8, pp 2387-2392, issn 0066-4804Article

Analysis of Low-Frequency Mutations Associated with Drug Resistance to Raltegravir before Antiretroviral TreatmentJIA LIU; MILLER, Michael D; DANOVICH, Robert M et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 3, pp 1114-1119, issn 0066-4804, 6 p.Article

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllersLAMBOTTEA, Olivier; FERRARI, Guido; HAYNES, Barton F et al.AIDS (London). 2009, Vol 23, Num 8, pp 897-906, issn 0269-9370, 10 p.Article

Predictors of Loss of Virologic Response in Subjects Who Simplified to Lopinavir/Ritonavir Monotherapy from Lopinavir/Ritonavir Plus Zidovudine/LamivudineCAMPO, Rafael E; DA SILVA, Barbara A; COTTE, Laurent et al.AIDS research and human retroviruses. 2009, Vol 25, Num 3, pp 269-275, issn 0889-2229, 7 p.Article

Resistance to HIV Integrase Strand Transfer Inhibitors Among Clinical Specimens in the United States, 2009-2012HURT, Christopher B; SEBASTIAN, Joseph; HICKS, Charles B et al.Clinical infectious diseases. 2014, Vol 58, Num 3, pp 423-431, issn 1058-4838, 9 p.Article

Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial ViremiaTOMARAS, Georgia D; YATES, Nicole L; COHEN, Myron et al.Journal of virology. 2008, Vol 82, Num 24, pp 12449-12463, issn 0022-538X, 15 p.Article

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the randomized evaluation of strategic intervention in multi-drug resistant patients with tipranavir (RESIST) studies : an analysis of combined data from two randomised open-label trialsHICKS, Charles B; CAHN, Pedro; VALDEZ, Hernan et al.Lancet (British edition). 2006, Vol 368, Num 9534, pp 466-475, issn 0140-6736, 10 p.Article

Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1RITOLA, Kimberly; PILCHER, Christopher D; FISCUS, Susan A et al.Journal of virology. 2004, Vol 78, Num 20, pp 11208-11218, issn 0022-538X, 11 p.Article

Prolonged CD4⁺ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: Immune response and oral controlSUFKA, Susan A; FERRARI, Guido; WEINHOLD, Kent J et al.The Journal of infectious diseases. 2003, Vol 187, Num 7, pp 1027-1037, issn 0022-1899, 11 p.Article

Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infectionFREEL, Stephanie A; FISCUS, Susan A; PILCHER, Christopher D et al.AIDS (London). 2003, Vol 17, Num 14, pp 2025-2033, issn 0269-9370, 9 p.Article

Antiretroviral Therapy Initiated During Acute HIV Infection Fails to Prevent Persistent T-Cell ActivationVINIKOOR, Michael J; COPE, Anna; GAY, Cynthia L et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 5, pp 505-508, issn 1525-4135, 4 p.Article

Evolution of Drug-Resistant Viral Populations during Interruption of Antiretroviral TherapyDONGNING WANG; HICKS, Charles B; GOSWAMI, Neela D et al.Journal of virology. 2011, Vol 85, Num 13, pp 6403-6415, issn 0022-538X, 13 p.Article

Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scoresWALMSLEY, Sharon L; COTTE, Laurent; RUSCONI, Stefano et al.AIDS (London). 2007, Vol 21, Num 16, pp 2245-2248, issn 0269-9370, 4 p.Article

Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4⁺/viral load discordanceKAPLAN, Susan S; FERRARI, Guido; WRIN, Terri et al.AIDS research and human retroviruses. 2005, Vol 21, Num 1, pp 13-16, issn 0889-2229, 4 p.Article